Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Radiol. Jul 28, 2012; 4(7): 318-323
Published online Jul 28, 2012. doi: 10.4329/wjr.v4.i7.318
Published online Jul 28, 2012. doi: 10.4329/wjr.v4.i7.318
Concurrent use of aromatase inhibitors and hypofractionated radiation therapy
Cyrus Chargari, Pablo Castro-Pena, Ivan Toledano, Marc A Bollet, François Campana, Alain Fourquet, Youlia M Kirova, Patricia De Cremoux, Department of Radiation Oncology, Institut Curie, 75005 Paris, France
Alexia Savignoni, Department of Biostatistics, Institut Curie, 75005 Paris, France
Paul Cottu, Department of Medical Oncology, Institut Curie 75005 Paris, France
Fatima Laki, Department of Surgery, Institut Curie, 75005 Paris, France
Patricia De Cremoux, Department of Pathology, Institut Curie, 75005 Paris, France
Author contributions: Kirova YM and Savignoni A designed the study; Castro-Pena P, Toledano I, Bollet MA, Savignoni A, Campana F, De Cremoux P, Fourquet A and Kirova YM contributed to acquisition of data; Chargari C, Savignoni A, Campana F, De Cremoux P, Fourquet A and Kirova YM interpreted the data; Chargari C and Kirova YM wrote the paper and revised it; and all authors approved the final version of the version to be published.
Correspondence to: Youlia M Kirova, MD, Department of Radiation Oncology, Institut Curie, 26, rue d’Ulm, 75005 Paris, France. youlia.kirova@curie.net
Telephone: +331-4432-4193 Fax: +331-4432-4616
Received: January 15, 2011
Revised: April 13, 2012
Accepted: April 20, 2012
Published online: July 28, 2012
Revised: April 13, 2012
Accepted: April 20, 2012
Published online: July 28, 2012
Core Tip